Literature DB >> 9811529

Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur.

M G Netea1, P N Demacker, B J Kullberg, L E Jacobs, T J Verver-Jansen, O C Boerman, A F Stalenhoef, J W Van der Meer.   

Abstract

Lipoproteins are able to bind to lipopolysaccharide (LPS) and neutralize its deleterious effects. However, it is not clear why the LPS-binding capacity of circulating lipoproteins, which is 10- to 10 000-fold above the maximal LPS concentrations found in septic patients, is not sufficient to inhibit the effects of LPS during an infection, whereas infusion of exogenous lipoproteins has a potent inhibitory action. In this study, the kinetics of LPS-neutralization by VLDL, LDL, and HDL were investigated, at lipoprotein-to-LPS ratios found in severe Gram-negative sepsis. At least 4-8-h preincubation of LPS with either LDL or HDL were necessary to inhibit 50% of the LPS-induced TNF-alpha production by human peripheral blood mononuclear cells (PBMC), whereas after 24 h of preincubation LDL or HDL strongly inhibited the TNF-alpha synthesis (70-90%, P<0.01). VLDL was the least effective lipoprotein fraction. In contrast, FITC-LPS bound to PBMC much more rapidly, with 70% of the total binding after 30 min, and 90% after 1-h incubation. The increase of LDL or HDL concentrations up to 10-fold (as in experimental models of hyperlipoproteinaemia) was able not only to further decrease TNF-alpha production after long LPS-lipoproteins preincubation periods, but also to improve the kinetics of LPS neutralization. In conclusion, LPS binds and stimulates the mononuclear cells in circulation before neutralization by endogenous lipoproteins can occur. Additional increase in the lipoprotein-to-LPS molar ratio (e.g. by infusion of exogenous lipoproteins) accelerates the kinetics of LPS neutralization, and may be useful as adjunctive therapy in severe Gram-negative infections. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811529     DOI: 10.1006/cyto.1998.0364

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  Endotoxemia-menace, marker, or mistake?

Authors:  Robert S Munford
Journal:  J Leukoc Biol       Date:  2016-07-14       Impact factor: 4.962

3.  Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells.

Authors:  M G Netea; N de Bont; P N Demacker; B J Kullberg; L E Jacobs; T J Verver-Jansen; A F Stalenhoef; J W Van der Meer
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

5.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.

Authors:  A C Vreugdenhil; A M Snoek; C van 't Veer; J W Greve; W A Buurman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

6.  Enteral administration of high-fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial translocation.

Authors:  Misha D P Luyer; Jan A Jacobs; Anita C E Vreugdenhil; M'hamed Hadfoune; Cornelis H C Dejong; Wim A Buurman; Jan Willem M Greve
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

Review 7.  Connection between Periodontitis-Induced Low-Grade Endotoxemia and Systemic Diseases: Neutrophils as Protagonists and Targets.

Authors:  Ljubomir Vitkov; Luis E Muñoz; Jasmin Knopf; Christine Schauer; Hannah Oberthaler; Bernd Minnich; Matthias Hannig; Martin Herrmann
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics.

Authors:  Jeroen van Bergenhenegouwen; Aletta D Kraneveld; Lieke Rutten; Johan Garssen; Arjan P Vos; Anita Hartog
Journal:  BMC Immunol       Date:  2016-10-28       Impact factor: 3.615

9.  Coordinated Induction of Antimicrobial Response Factors in Systemic Lupus Erythematosus.

Authors:  Prathapan Ayyappan; Robert Z Harms; Jane H Buckner; Nora E Sarvetnick
Journal:  Front Immunol       Date:  2019-04-04       Impact factor: 7.561

10.  Presentation matters: Impact of association of amphiphilic LPS with serum carrier proteins on innate immune signaling.

Authors:  Loreen R Stromberg; Heather M Mendez; Jessica Z Kubicek-Sutherland; Steven W Graves; Nicolas W Hengartner; Harshini Mukundan
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.